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ABSTRACT

The Effects of Exercise on Homocyteine Levels in Men and Women
by
Tracey Michelle Zuehlsdorff
Dr. Lawrence Golding, Examination Committee Chair
Professor of Kinesiology
University of Nevada, Las Vegas
A recent coronary risk factor,and one believed to be and important biochemical
marker o f Coronary Heart Disease, is elevated levels of serum homocysteine (Boushley
et al., 1995; Malinow et al., 1994; Malinow et al., 1999; Nygard et al., 1995; Stampfer et
al., 1992). Serum homocysteine levels above 10 umol/L are considered elevated. There
are several unalterable factors, which result in the elevation of homocysteine such as
heredity, age, and gender. There are other factors that are alterable such as diet and
possibly exercise. The purpose of the study was to determine if a 12-week daily
progressive exercise program reduced homocysteine levels in men and women. Six men
and four women between the ages of 32 and 50 years of age participated in the study.
The subjects were all sedentary, business or professional individuals who joined the study
to improve their physical fitness. Subjects’ homocysteine levels were 10 umol/L or
greater. The female subjects were all premenopausal. Homocysteine levels were
assessed before and after the 12-week exercise program and a dependent t test evaluated
the changes (oc = .05). After the 12-week exercise program the analysis revealed a
significant reduction in
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homocysteine levels (t = 5.71, p<.05) providing evidence that regular exercise reduces
homocysteine levels in men and women.
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CHAPTER 1

INTRODUCTION
Cardiovascular disease is the major cause of death in the United States, and the
American Heart Association has publicized the factors involved in the development of
Coronary Heart Disease (CHD). These coronary risk factors include hypertension,
elevated total cholesterol levels, cigarette smoking, sedentary living, obesity,
uncontrolled diabetes, and others. One of the more recent factors, and one believed to be
an important biochemical marker, of CHD is elevated levels of serum Homocysteine
(Boushey et al., 1995; Malinow et al., 1994;Malinow et al., 1999; Nygard et al., 1995;
Stampfer et al., 1992). Homocysteine (hcy) is derived from the metabolism of the amino
acid methionine. Normal serum homocysteine levels are below 10 umol/L; borderline
elevated homocysteine is between 10 and 15 umol/L; and elevated homocystiene is
identified as 15 umol/1 or greater (Spectra Cell Lab). Elevated homocysteine is termed
hyperhomocystienemia. Even though most laboratories consider homocysteine levels
between 5 and 15 umol/L as the normal range, studies (Ségala et al., 2000) have shown
that homocystiene levels above 6.3 umol/L result a progressive risk of coronary heart
disease. Wilcken and colleagues in 1976 (Spectra Cell laboratories) first demonstrated a
relationship between elevated homocystiene levels and cardiovascular disease. They
showed that patients with premature atherosclerosis had elevated hcy levels in
comparison to control subjects. Since 1976, several studies have shown high
1
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homocystiene levels with the increased incidence of heart disease (Boushey et al., 1995;
Malinow et al., 1994; Nygard et al., 1995; Stampfer et al., 1992; Kang et al., 1986).
Blood homocystiene levels tend to increase with age (Nygard et al., 1995). However,
hyperhomocysteinemia is observed in 30% of patients with known coronary artery
disease and 42% of patients with cerebrovascular disease (Stein et al., 1998). The
American Heart Association has reported that moderate and intermediate
hyperhomocysteinemia is present in 47% of patients with coronary, cerebral, or
peripheral arterial occlusive diseases (Malinow et al., 1999). The Physician’s Health
Study (Stampfer et al., 1992) studied 14,916 apparently healthy male physicians for five
years, of which 271 subsequently developed myocardial infarctions. The homocysteine
levels were significantly higher in the physicians who suffered the myocardial
infarctions. Malinow et al. (1989) followed 47 patients with peripheral arterial occlusive
disease and in all cases plasma homocysteine was elevated. In another study Malinow et
al. (1996) found elevated homocysteine levels in 40% of patients with coronary heart
disease.

There is considerable evidence to link elevated homocysteine levels and heart

disease (Malinow et al., 1989; Malinow et al., 1996; Stampfer et al., 1992).
There are several factors resulting in elevated homocysteine levels: heredity, age,
and gender. These factors are unalterable, however, some factors, such as diet, are
alterable (Nygard et al., 1995; Malinow et al., 1996; Genest et al., 1991 ; William et al.,
1990; Malinow et al., 1999; Moustapha et al., 1999). Heredity is considered one of the
greatest reasons for elevated homocystiene. Several studies (Malinow et al., 1996;
Genest et al., 1991; Williams et al., 1990) have linked heredity to elevated homocysteine
levels. An autosomal recessive genetic disorder called Homocysteinuria effects 1:200,
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000 births. This condition is caused by inherited errors of metabolism and can cause
skeletal abnormalities, mental retardation, and a high incidence of heart disease (Malinow
et al., 1999). Age and gender are two other unalterable factors in elevated homocysteine
levels, homocysteine levels tend to increase with age, and males tend to have higher
homocysteine levels than females (Nygard et al., 1995). In females homocysteine levels
tends to increase after menopause and decrease during pregnancy. However,
postmenopausal women can control the increase in homocysteine by using estrogen
replacement therapy (Nygard et al., 1995; Moustapha et al., 1999).
One important factor often resulting in elevated homocysteine levels is diet. Diet,
and in particular the amount and kind of vitamins consumed, can be controlled and these
tend to effect the homocysteine level. Consuming or supplementing the RDA for
Vitamin B6, B12, and folic acid normally prevents elevated homocysteine levels. The
RDA for folic acid is 400 ug/day, the RDA for B6 is 2.0 mg/day, and the RDA for BI2 is
3.0 ug/day (Malinow et al., 1999). Due to poorer absorption in older adults, maintaining
adequate vitamin intake is especially important. If the recommended amount of these
vitamins is not being met by diet alone, then supplementation is recommended.
One of the most accepted coronary risk factors is elevated serum cholesterol
levels. Several studies have shown that exercise lowers total cholesterol levels and
increases HDL cholesterol, which decreases the risk for cardiovascular disease (Gordon
et al., 1994; Lennon et al., 1983; Grouse et al., 1997; Hubinger et al., 1992). Lennon and
associates (1983) showed that 40 minutes of exercise increases HDL cholesterol,
decreases total and LDL cholesterol. Hubinger and colleagues (1992) demonstrated that
30 minutes of moderate exercise made a significant increase in HDL cholesterol. Gordon
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et al. (1994) demonstrated the importance of the intensity of exercise: a moderately
trained male working at 75% of V 02 max increased HDL cholesterol levels significantly.
It was suggested that those with higher baseline levels of HDL cholesterol might require
longer duration exercise to achieve the same affect. Crouse and colleagues (1997)
demonstrated that a single bout o f exercise had a significant affect on lipid concentration
in hypercholesterolemic men: it increased HDL cholesterol and decreased total
cholesterol and with continued training there was a significant decrease in LDL
cholesterol.
The evidence indicating that exercise reduces total cholesterol suggests that
exercise may also beneficially affect homocysteine levels. Since elevated homocysteine
levels are an important risk factor for cardiovascular disease, the effects of exercise on
homocysteine levels needs to be investigated. Nygard et al. (1995) demonstrated a linear
relationship between total homocysteine levels and total and LDL cholesterol levels.
Therefore, it could be hypothesized that when high LDL cholesterol levels persist, high
homocysteine levels may be expected. Since exercise has been shown to lower
cholesterol, it is also possible that exercise may lower elevated homocysteine levels.
To date, only two studies have examined the effect of exercise on homocysteine
levels. The Norwegian Hordaland Homocysteine Study (Nygard et al., 1995) studied
8,585 women and 7,591 men, between the ages 40 to 67 years. The purpose of this study
was to investigate the relationship between homocysteine levels and other cardiovascular
risk factors. The investigators determined that homocysteine levels were inversely
related to physical activity. The men that participated in exercise had an average of a
1.08 umol/L lower total homocysteine levels than their sedentary counterparts and the
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women had an average of a .65 umol/L lower level than sedentary subjects. However, in
another study, Wright et al. (1998) found that the one bout of acute exercise had no affect
on homocysteine levels. In their study 20 healthy young males ran on a treadmill at 70%
of their max heart rate for 30 minutes.

Statement of the Problem
The purpose of the present study was to investigate the effects of a 12-week daily
exercise program on homocysteine levels in men and women aged 32 to 50 years. The
hypothesis was that regular, progressive exercise significantly lowers elevated
homocysteine levels. The research question was: Does persistent regular exercise reduce
homocysteine levels?

Need for the Study
Since homocysteine has been determined to be an important biochemical marker
of coronary heart disease, it was desirable to know if regular, daily exercise positively
effects homocysteine levels.

Limitations and Assumptions
Limitations:
1. The financial laboratory cost of determining homocysteine levels and the limited age
range of the subjects, limited the number of subjects. Since females needed to be
premenopausal, women over 50 years of age were not used.
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2. A 12-week exercise program was used. A longer program of exercise may produce
different results.
3. Some dietary information was obtained from the subjects, but it was not possible to
rigorously control diet or supplementation use even though they were asked not to
change or modify their diets and not to begin any diet supplementation during the
study.
4. Since heredity is an unalterable factor involved in elevated homocysteine, it was not
possible to know the level homocysteine due to heredity.
5. Although women were screened for menopausal status, it was not possible to be
completely assured that all the women involved were premenopausal.
6. Study was limited to those that had serum homocysteine levels of 10 umol/L or
greater.

Assumptions:
1. Subjects were asked to attend at least 3 of the 5 days of exercise each week.
Attendance was taken, and it was assumed that individuals worked diligently while in
the exercise sessions.
2. Subjects were asked to not change their diets and not begin taking any supplements.
It was assumed that they followed those requests
3. Subjects were asked if they were sedentary before the study. All reported that they
were sedentary. Therefore it was assumed that they were sedentary previous to
beginning the exercise program.
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4. Subjects all reported and signed consent forms that indicated that they were free of
any heart disease or other major health complications.
5. It was assumed that all women that participated were premenopausal at the time of
the study.
6. It was assumed that the Homocysteine levels were accurately assessed.
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CHAPTER 2

LITERATURE REVIEW
Medical Discovery
The interest in homocysteine started in 1933 when an eight-year-old boy was
admitted to the Massachusetts General Hospital with symptoms of headaches,
drowsiness, and vomiting, he also had signs of mental retardation and the lenses of both
eyes were detached. The boy had indications of a stroke and died a few days later. The
cause of death was recorded as arteriosclerosis of the carotid artery with a cerebral
infarct, even though this was usually a condition reserved for older adults (McCully,
1997). This case was basically ignored for thirty-two years, and then in 1965, a young
girl was evaluated at the same hospital for retarded mental development and had similar
symptoms of the boy thirty -two years previous. The eight-year-old boy that had died 32
years earlier was the young girl’s uncle (McCully, 1997). This was later determined to be
a result of elevated homocysteine levels. In 1962 in Belfast, Ireland doctors studying the
composition of urine in mentally retarded individuals found elevated homocysteine levels
and the term homocysturinia was used (McCully, 1997). Homocysteine was analyzed in
the urine as an amino acid formed from the normal breakdown of the proteins. The
symptoms of the young girl and boy mentioned above were similar to those discovered in
homocysturinia. The young girl was tested for elevated homocysteine, and was
diagnosed with homocysturinia. After elevated homocystiene and homocystinuria

8
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became more diagnosable, research in the United States on elevated homocysteine began
being published (McCully, 1997).

Metabolism
Homocysteine (hcy) is an amino acid formed from methionine. Excess
methionine in the diet is converted to homocysteine. The RDA for methionine is .9
g/day; however, the average American diet usually contains approximately 2 g/day of
methionine (Stein et al., 1998). Methionine is found in all proteins and animal foods such
as meat, eggs, milk, and cheese which contain more protein than most foods of plant
origin. The RDA for protein based on weight is approxiamately 60 grams for adult men
and 50 grams for adult women (McCully, 1997). The metabolism of homocysteine starts
when methionine is introduced into the digestive tract. Methionine combines with an
ATP molecule and forms S-adenosylmethionine (SAM), an intermediate, which then
gives up a methyl group and becomes homocysteine. Homocysteine can then either be
further metabolized by the transulfuration pathway to cystathionine and cysteine with the
excretion o f sulfur in the urine or it is remethylated by one of two pathways back into
methionine (Carmel R & Jacobsen D, 2001).
In transsulfuration, homocyteine, in the presence of vitamin B6 and the enzyme
cystathionine B-synthase combines with serine to form cystathionine from which
cysteine, a-ketobutyrate, and ammonium are formed. This process produces the secretion
of sulfur in the urine. Homocysteine can then be remethylated back into methionine by
one of two pathways. One of the two pathways requires Vitamin B12 and allows
homocysteine to pick up a methyl group from methyltetrahydrofolate, a folic acid
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derivative, catalyzed by homocysteine methyltransferase (FHMT), forming methionine.
The remaining tetrahydrofolate to then form 5, 10 methylene-tetrahydrofolate and
continues through the metabolic pathway. In the other remethylation pathway, betaine
donates a methyl group to homocysteine and forms methionine, and dimethylglycine. The
two metabolic pathways tend to compete for the available homocysteine. Figure 1 on the
next page illustrates the process.
Studies have demonstrated that in young adult men fed a diet adequate in
methionine (14mmol/day), about 38% of homocysteine is remethylated to methionine
and 62% is catabolized by transsulfuration (Shils et al., 1999). Elevations in
homocysteine levels occur primarily through a genetic deficiency of cystathionine B
synthase (CBS). With a deficiency in CBS, the transulfuration pathway for homocysteine
metabolism is not possible. Other possible causes of elevated homocysteine levels occur
with deficiencies in Vitamins B6, B12, and folic acid. Without these vitamins, the
transulfuration and transmethylation pathways are not effective. Therefore, homocystiene
cannot be excreted nor can it be reformed back into methionine. Although, these are the
most common causes of elevated homocysteine levels, any error that does not allow
homocystiene to either by excreted or remethylated into methionine has the potential to
cause elevated homocystiene levels.
Total plasma homocysteine is the sum of all free homocysteine and protein-bound
homocysteine. According to Spectra Cell Laboratories, mean value for normal total
homocysteine is 10 umol/L and generally 10% higher in men than women and increases
with age. Some research (Malinow et al., 1999) has indicated in the fasting patient,
normal levels of plasma homocysteine are between 5 and 15 umol/L. However, according
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to McCully (1997) if blood homocysteine levels can be kept below 10 umol/L a
significant measure o f protection against development and progression o f arteriosclerosis
is assured. Even though some laboratories find homocysteine levels between 5 and 15
umol/L to be in a normal range, studies (Segala, 2001) have shown that homocysteine
levels above 6.3 umol/L cause a steep and progressive risk of heart attack.

Methionine
ATP

t
^

X \
THF ,

N 5,10 Methylene-THF

T 1J

Dimethyl-glycine
f

SAM

^
R

Methyl-cobalamin

Betaine

>R-CH3
S-A densosine-hcy

B12, Folate
Choline
N5 Methyl-THF

Homocysteine
Serine

I

Requiring B6

Cystathionine

©

i
Cysteine + ketobutyrate + NH4

Figure 1: Methionine Metabolism
1. Methionine combines with ATP and forms S-adenosylmethionine (SAM), which
forms Homocysteine.
2. Transulfuration pathway of homocysteine requiring Vitamin B6.
3. One remethylation pathway requiring Vitamin B12 and folate.
4. The second remethylation pathway requires betaine as a methyl donor to form
methionine.
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Homocystinuria is a genetic disease that affects the metabolism of homocysteine.
This is a rare autosomal recessive genetic disorder that approximately affects 1:200,000
births (Malinow et al., 1999). Homocystinuria results from severe
hyperhomocysteinemia caused by abnormaility of the metabolism of homocysteine.
There are three possible mechanisms for the abnormality of hcy metabolism; the first and
most common cause is a lack of cystathionine B-synthase activity that can cause plasma
homocysteine levels as high as 200 umol/L in untreated patients (Shils et al., 1999). The
second common cause is a lack of N-methylenetetrahyrofblate reductance activity, which
affects folate metabolism. The third possible cause of homocystinuria is an error in the
synthesis of methylocobalamin (Shils et al., 1999). Overall, those with homocystinuria
have a high incidence of vascular pathology that can lead to myocardial infarction,
stroke, or pulmonary embolism (Malinow et al, 1999). Homocystinuria that is caused by
a cystathionine B synthase deficiency can lead to dislocation of optic lenses, skeletal
abnormalities, mental retardation, and neurological disorders (Shils et al, 1999).
Fortunately, newborn screening for homocystinuria detects a CBS deficiency by primary
screening for hypermethioninemia and secondary screening for elevated urine and/or
plasma homocysteine levels (Shils et al, 1999).

Homocysteine and Heart Disease
Elevated homocysteine level is presently an important biochemical marker for
coronary heart disease. Several studies have shown a positive correlation between
elevated hcy levels and the incidence of coronary heart disease (CHD). In 1992 Stampfer
and his colleagues did one of the first prospective studies on homocysteine and CHD and
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was entitled The Physicians Health Study. These researchers followed 14, 916 male
physicians between the ages o f 40 and 84 years of age who, prior to the study, had not
had any known myocardial infarctions or strokes. The homocysteine levels of the
physicians were analyzed, compared and matched to their controls for five years. Two
hundred seventy one o f the physicians developed a myocardial infarction, and these had
elevated homocysteine levels above 11 umol/L. Thirty one of the cases had
homocysteine levels greater than 15.8 umol/L, which was found to be significant. This
proportion would probably be higher in the general population, which is presumably less
well nourished than US physicians. Selub and others (1995) showed a significant
relationship between Carotid Artery Stenosis and elevated total homocysteine levels and
low concentrations of folate and vitamin B6. They studied 1,041 men and women
between the ages of 67 and 97 years from the Framingham Heart Study, which was a
study done with a group of patients from Framingham, Massachusetts with coronary
heart disease. The relationship between the maximal degree of stenosis of the extracranial
carotid arteries and plasma homocysteine along with concentrations and intakes of folate.
Vitamin B6, and B12 were examined. The study showed that high plasma homocysteine
concentrations and low concentrations of folate and Vitamin B6 were associated with an
increased risk o f extracranial carotid-artery stenosis in the subjects.
Although the precise mechanisms by which elevated homocysteine can causes
vascular damage is not completely understood, it is hypothesized that endothelial injury
is a probable factor (Berwanger et al., 1995). It is speculated by researchers (McCully,
1997; Malinow et al., 1993; Graham et al., 1997) that elevated homocysteine levels cause
endothial dysfunction and aggregation of platlets by promoting oxidation at the cellular
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level. This oxidation process increases LDL accumulation and enhances foam cell
formation which leads to the progression o f occlusive arterial diseases. Studies have also
correlated elevated homocystiene levels with peripheral arterial occlusive disease
(PAOD) (Boers et al., 1985; Clarke et a., 1991; Malinow et al., 1989). Malinow et al.
(1989) studied 47 patients with PAOD, 35 cases had carotid arterial involvement and 32
subjects also had ileo femoral lesions, therefore, occlusion was found in both arterial
areas in the about 80 % o f the subjects. The results of the study showed that plasma
homocysteine levels were elevated in the patients with PAOD when compared to their
controls. Malinow et al., (1993) showed a correlation of elevated homocysteine to
carotid arterial wall intimal-medial thickness in 287 case-controlled pairs of individuals
free of clinical athersclerosis. Subjects for the study were selected from a sample of
15,800 men and women between the ages of 45 and 64 years of age. The study revealed
that the subjects with thickened carotid wall or occlusive arterial disease are more likely
to have elevated homocysteine levels that their controls. Elevated homocystiene levels
have also been noted in patients with cerebrovascular disease (Boers et al., 1985;
Brattstrom et al., 1990; Clarke et al., 1991; Malinow et al., 1996). Brattstrom et al.
(1992) matched 142 stroke survivors with 66 control subjects that were free of
cerebrovascular disease. They found hyperhomocysteinemia present in 40% of stroke
patients and only 6% of control subjects.

Vitamin Deficiency and Supplementation
Besides genetic factors, vitamin deficiency is the most common cause of elevated
homocysteine levels. Inadequate plasma concentrations of vitamin B6, B12, and/or folate
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contribute to 67% of cases of hyperhomocysteinemia (Spectra Cell Lab). The RDA for
vitamin B6 is 2.0 mg/day and foods include fortified cereals, noncitrus fruits, poultry,
beef, and vegetables such as artichokes, beans, cabbage, and asparagus. The RDA for
vitamin B12 is 3.0 mcg/day and food sources include beef, poultry, and fortified cereals.
Lastly, the RDA for folic acid is 400 meg and foods containing folic acid include fortified
cereals, leafy green vegetables, fruits, and legumes (Malinow et al., 1999). However, the
majority of the population does not meet the RDA requirements for these vitamins, and in
addition, due to reduced absorption with age, this is most prominent in those over the age
o f 50 (Malinow et al., 1999). Therefore, supplementation of these three vitamins is
recommended. Both folate and vitamin B12 are cofactors for methionine synthase and
are needed to remove homocysteine.
In Vitamin B6, B12 and folate deficiency homocysteine is not metabolized and its
concentration in the blood rises (Pancharuniti et al., 1994). O f the three vitamins
involved in homocysteine metabolism, supplementation with folate seems to be the most
successful in lowering high homocysteine levels (Franklin et al., 1998). Stein et al.
(1998) have shown that folic acid supplementation of 400 meg or more a day can
decrease total Hcy levels up to 42%. However, supplementation with a combination of
all three vitamins (Vitamin B6, B12, and Folate) results in a 72% reduction in total
homocysteine. The American Heart Association recommends a folic acid dose between
.2 and 15 mg/day to lower hcy levels. In addition, the AHA showed that the daily intake
of fortified cereals, which contain 499 to 650 ug of folic acid per serving, and the RDA of
the vitamin B6 and B12, can reduce homocysteine by 14%. However, there is a small
danger with folic acid supplementation. A high folate intake may mask the development
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o f megaloblastic anemia characteristics of older patients with vitamin B12 deficiency
(Moustapha et al., 1999). Therefore, it is important to screen older adults for vitamin
B12 deficiency before beginning treatment for elevated hcy. Research (Boushley et al.,
1995) has demonstrated that large doses o f folic acid (5000 ug) are not necessary to
reduce hyperhomocysteinemia. A folic acid dose of 650 ug reduced homocysteine
concentrations by 42% in subjects. Boushley and others showed that there was no
additional lowering o f hcy after six weeks of treatment with 1000 meg folic acid per day,
0.4 mg/day o f B12, and 12.2 mg/day of B6 when twice these amounts were given. This
suggests that there may be an upper limit in supplementation as it relates to homocysteine
reduction.
Although, folic acid is very effective in reducing homocysteine, combination
therapy with vitamin B6 and B12 is suggested (Boushley et al., 1995). Cobalamin (B12)
supplementation alone is only successful in reducing total homocysteine levels in cases of
overt B12 deficiency (Boushley et al., 1995). Boushley and associates (1995) showed
that pyridoxine (B6) is not effective in reducing elevated fasting total homocysteine
levels when used alone. A few other vitamins that may affect homocysteine levels
include riboflavin and nicotinic acid. Riboflavin can function as a cofactor for
methylenetetrahydrofolate reductace (MTHFR), which is the enzyme that regulates the
metabolic pathway for homocysteine. A .6 mg/day food intake of riboflavin can slightly
reduce total homocysteine. On the other hand supplementations of 3000 + mg/day of
nicotinic acid may elevate homocysteine levels. Research reported by the American
Heart Association, (Malinow et al., 1999) has shown that users of multivitamin
supplements have lower homocysteine levels that nonusers. McKay et al. (2000)
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reported lower homocysteine levels and improved vitamin B status with
multivitamin/mineral supplementation. The study involved 80 men and women between
50 and 87 years o f age with homocysteine levels of > 8 umol/L. Each subject received a
multivitamin/mineral supplement or a placebo for 56 days while consuming their normal
diets. The results showed plasma folate, pyridoxal phosphate, and vitamin B-12
concentrations were increased 41.6, 36.5, and 13.8 %, respectively and no changes were
observed in the placebo group. Mean homocysteine concentrations decreased 9.6% in the
supplementation group, as well.

Heredity
Several studies have studied the heritability of plasma homocysteine in families.
Malinow et al. (1996) reported various studies (Genest et al., 1991; Reed et al., 1991;
Berg et al., 1992) that have shown hyperhomocysteinemia can be an inherited
abnormality and possibly explains cases of early familial coronary artery disease. Genest
and colleagues (1991) studied families of patients with premature CAD (coronary artery
disease) to determine whether the hyperhomocysteinemia was familial. Subjects
consisted o f 176 men less than 60 years of age that had been diagnosed with CAD. Two
hundred and fifty-five control subjects were also examined. The families of 71 of the
subjects were also examined. Family included spouses and first generation relatives,
resulting in a total o f 370 subjects. The results showed that 20 families had elevated hey
levels compared to controls and that 14% of the CAD patients did have familial
hyperhomocysteinemia. Therefore, elevated homocysteine levels are partially genetically
determined in individuals with CAD. Williams et al. (1990) measured homocysteine
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levels in 37 men and women with CAD and in 30 male and 18 female control participants
who were matched for age and sex. Participants of the study were selected to include 13
male sibling pairs with CAD, 13 male sibling pairs as control subjects and 13 spouse
pairs as control subjects. The results showed significantly higher hey levels in CAD
patients, among 26 male sibling pairs, a strong familial correlation of homocysteine was
observed. The above studies suggest that hyperhomocysteinemia was and inherited
abnormality and may explain certain cases of early familial CAD (Malinow et al., 1996).

Age
Advancing age is a contributing factor in elevated homocystiene levels. There is
a high correlation between homocysteine and age indicating that total homocysteine
levels increase in older individuals with or with out cardiovascular disease. Nygard and
others (1995) revealed higher total homocysteine levels in men and women as their age
increased. Their study examined 7,591 Norwegian men and 8,585 Norwegian women
between the ages of 40 and 67 years. There are several causes for increasing hey levels
with age. The production of Cystathionine B synthase and other enzymes involved in
homocysteine metabolism tend to decline with age (Moustapha et al., 1999). Due to a
decrease in the absorption of folate, vitamin B12 and B6 with age, an increase in
homcysteine can occur (Moustapha et al., 1999). The amount of food consumed also
tends to decline with age, which causes a decline in the dietary intake of Vitamin B6,
B12, and folic acid. One study (vonEckardstein et al., 1999) found that elevated
homocystiene levels are_significantly correlated with age, among other factors such as
fibrinogen and plasma viscosity in CAD patients. Overall, age is an unalterable factor.
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which, can lead to elevated homocysteine levels. Therefore it is advisable to become
aware o f the alterable factors such as diet.

Gender and Menopause
Nygard et al. (1995) indicated that because of a larger muscle mass and creatine
synthesis, men tend to have higher homocysteine levels than women. In females,
premenopausal women have lower homocysteine levels than postmenopausal women.
However, postmenopausal women on estrogen replacement therapy tend not to have
elevated homocysteine levels (Nygard et al., 1995; Malinow et al., 1994). This finding
suggests that premenopausal women remethylate homocysteine to methionine better or
that their transulfuration rate or renal excretion differs from postmenopausal women
(Carmel, Jacobsen, 2001). Nygard et al. (1995) also indicated that increased levels of
plasma estrogens may account for lower hey levels in pregnant women. However,
Henderson (2000) showed no correlation between estrogen and homocysteine. He
measured homocysteine levels before and after six months of estrogen replacement
therapy and found no significant changes in homocysteine levels.

Homocysteine and Cholesterol
Elevation in plasma homocysteine levels are found with increased levels of
cholesterol and triglycerides (Karmin et al., 1998; Glueck et al., 1995). Nygard and
associates (1995) found a positive correlation between total homocysteine and total
cholesterol and LDL cholesterol when examining the relationship between cardiovascular
risk factors and total homocysteine in plasma. According to Karmin et al. (1998)
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homocysteine stimulates the production and secretion of cholesterol in hepatic cells. In
his study, hepatic cells were incubated with 4mM of homocysteine. This amount (4mM)
is considerably higher than that found in the plasma of homocysteinemic patients because
the chronic process of homocysteine in patients cannot be readily produced when using a
cell culture model The results showed that homocysteine produced an elevated
cholesterol level in the hepatic cell and stimulated the secretion of cholesterol by the
cells. Glueck and others (1995) studied 482 patients with hyperlipidemia. Homocysteine
levels were measured in all subjects and 18 of the 482 patients had elevated
homocysteine levels (> 16.2 umol/L). However, of the 18 with elevated homocysteine,
13 had atherosclerotic vascular disease. Zulli and others (1998) found a positive effect
among cholesterol, homocystiene, and triglyceride levels. The study used rats and fed
them a control diet which consisted of a high cholesterol supplemented diet, a high
methionine supplemented diet, and a combination of the two, a high cholesterol plus a
high methionine supplemented diet. The results of the study showed that excess
methionine and cholesterol feeding act positively to increase plasma homocysteine,
cholesterol, and triglyceride levels. The methionine only diet showed an increase in
homocysteine and the cholesterol only diet showed an increase in homocysteine, but the
combined diet had the greatest effect and showed the greatest increase in homocysteine.
Zulli and associates believed that humans show the same effect, therefore indicating that
elevated levels of cholesterol increase homocystiene levels.
Elevated HDL cholesterol levels have been known to reduce overall risk of
coronary heart disease. In contrast to the above studies Superko et al. (1997), reports that
despite the protective effects that elevated HDL cholesterol has, athersclerosis can still
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occur in the setting of hyperhomocysteinemia. In his study, he reported an 82 year old
women with elevated HDL cholesterol and normal LDL cholesterol levels with coronary
artery disease. However, the patient did have elevated homocysteine levels. Therefore,
there is a conflict in the research. However, Superko’s study only looked at one subject.

Homocystiene and Ethnicity
There is not total agreement on the effect of ethnicity and elevated hey levels.
Gerhard et al. (1999) concluded that premenopausal black women tend to have two to
three times the incidence of CHD than similar white women. In addition, black women
had higher levels o f homocysteine levels than white premenopausal women. The study
was conducted using 89 black women and 90 white women between the ages of 18 and
45. The result showed that total homocysteine levels were significantly higher and
plasma folate levels were significantly lower in the black women compared to their white
counterparts. In contrast, Giles et al. (1999) concluded that there is no difference in
homocysteme levels among different ethnic groups. The study examined data from the
Third National Health and Nutrition Examination Survey. This was a survey that was
used to examine the relationship between total homocysteine levels in 3,173 patients with
acute myocardial infartions among whites, hlacks, and Mexican Americans over 40 years
of age. The study revealed that there is an increase in the likelihood of myocardial
infarction among those with elevated homocysteine levels (>15 umol/L), but
homocysteine levels did not differ among blacks, whites, and Mexican Americans. Due
to the inconsistent results of the two studies, further research is needed to determine the
relationship between homocysteine levels and ethnicity.
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Diabetes and Kidney Disease
Diabetes mellitus has been associated with heart disease (McCully, 1997; Bostom
et al., 1994; Chauveau et al., 1993; Freidman et al., 1995). Diabetics often suffer from
heart attack, stroke, kidney failure, blindness, and gangrene. A few of these ailments are
a result of atherosclerosis. An adverse effect of kidney failure, whether it is from
diabetes or other causes, is a large build up of homocysteine in the blood. The levels of
homocysteine can become extremely high, sometimes reaching two to three times the
normal values (McCully, 1997). According to Bostom et al. (1994), who examined a
group o f 24 patients between the ages of 35 and 70 years with End-Stage Renal Disease
(ESRD) on maintenance dialysis. Subjects were matched with controls. Plasma
homocysteine levels were higher in ESRD patients than in controls. Vitamin B
concentrations were also examined in the above patients and elevated homocysteine
levels were also apparent in the ESRD patients with normal and above normal vitamin B
levels, suggesting that vitamin status in an independent factor. Chauveau et al. (1993)
examined 118 adults with end stage renal disease (ESRD), 79 of the patients were not on
dialysis and 39 patients were on maintenance dialysis. All subjects were matched for
controls. The 79 nondialyzed patients did not receive any vitamin supplementation and
had homocysteine levels two to four times greater than their controls. O f the 39 patients
on maintenance dialysis all received adequate levels of Vitamin B12 and folate and still
had elevated postdialysis homocysteine levels. Overall, the study showed that as renal
function decreased, homocysteine levels increased. Therefore there is evidence that
patients with renal failure have high homocysteine levels. Individuals receiving dialysis
treatment, either hemodialysis or continuous peritoneal dialysis still may show elevated
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hey levels, although homocysteine levels tend to be even more elevated in imtreated
patients (Freidman et al., 1995). The above research also indicates that vitamin therapy
does not decrease those levels of homocysteine in patients with renal disease.

Homocysteine and Alzheimer’s Disease
Alzheimer’s disease and dementia has been related to athersclerosis and vascular
disease (Perry et al., 1999; Bell et al., 1992; Clarke et al., 1998; McCadden et al., 1998).
The relationship between the two began in the late 1980’s with The Oxford Project to
Investigate Memory and Aging (OPTIMA). OPTIMA is an ongoing study that was
established in 1988 to study Alzheimer’s disease and all factors that affect it. The
projects found research to link elevated levels of homocysteine causing damage to the
blood vessels in the brain resulting in the development of Alzheimer’s disease (Perry,
1999). McCaddon et al. (1998) studied 30 subjects 65 years or older with Alzheimer’s
disease and found a significant relationship between homocysteine levels and scores of
the Cambridge Cognitive Examination (CAMCOG), which is the cognitive assessment
for elderly individuals with mental disorders. The test assesses retention skills and short
term memory skills. Clarke et al. (1998) found a significant relationship between
homocysteine levels and scores on the Cambridge Cognitive Exam and a Mini-Mental
State Exam (MMSE). The MMSE assesses a combination of orientation skills, ability to
follow directions, and attention skills. Homocysteine levels, serum folate and vitamin
B12 levels were also examined. The study showed lower levels of vitamin B12 and
folate in the Alzheimer’s patients with elevated homocysteine levels. The study by
Clarke et al. (1998) also suggests that adequate amounts of folate and B12 may reduce
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the risk of Alzheimer’s disease. Research has fovmd that Alzheimer’s patients as well as
those with dementia tend to have lower levels of the two vitamins than those with normal
brain function (Tufts University Health & Nutrition Letter, 1999). Higher levels of
homocysteine have been shown to reduce the ability to learn and remember, especially
with the association o f low levels of folate and Vitamin B12 (Miller et al., 1999). Riggs
et al. (1996) demonstrated this by giving a battery of cognitive tests to 70 male subjects
between the ages of 54 and 81 years. As a result, lower levels of both vitamins correlated
with a high concentration of homocysteine, which produced a poor memory response.
The higher levels o f folate and B12 improved the outcomes of the cognitive exams on
two measures of memory.
The correlation between elevated homocysteine levels and individuals with
Alzheimer’s type dementia is not fully understood, however, scientist have reported that
people with Alzheimer’s disease have no S-adenosylmethionine (SAMe) in their brains,
which is required for maintenance and repair of the brain cells (Segala, 2001).

Summary
The discovery of homocysteine dates back to the 1933 with the death of a young
boy with symptoms normally associated with older adults. It was not until the 1965 when
the cause o f death was determined to be homocysturinia. From the time of discovery
until now, research involving homocysteine has been extensive and continues to expand.
Elevated homocysteine levels have become an important biochemical marker for
coronary heart disease (CHD). Several studies (Stampfer et al., 1992; Selub et al., 1995;
Malinow et al., 1995; Malinow et al., 1989; Berwanger et al., 1995) bave shown a strong
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correlation between elevated homocysteine levels and CHD, cerebrovascular disease, and
peripheral arterial occlusive disease.
There are several factors leading to the causes of elevated homocysteine levels
such as heredity, age, and gender. These factors are unalterable, there are some factors
that are alterable such as diet and possibly exercise (Nygard et al., 1995; Malinow et al.,
1996; Genest et al., 1991; William et al., 1990). Elevated homocysteine is more common
in those that demonstrate an inherited factor; as well elevated homocysteine is more
common in older adults rather than younger adults. Homocysteine levels are commonly
higher in men than in women. However, postmenopausal women tend to have higher
levels than premenopausal women due to the related estrogen status.
Elevated homocysteine levels have been associated with increased levels of
cholesterol and triglycerides (Karmin et al., 1998; Glueck et al., 1995). However, more
research is needed in this area. Due to inconsistent results (Gerhard et al., 1999; Giles et
al., 1999) research is needed to determine the relationship between homocysteine levels
and ethnicity. Other areas o f research related to elevated homocysteine levels include
diabetes, kidney disease, and Alzheimer’s disease. These also show a correlation with
elevated homocysteine levels.
Homocysteine has been widely researched and related heart disease. Both
unalterable risk factors and alterable risk factors have been examined. However, more
research is needed to determine the effect exercise has on homocysteine levels.
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CHAPTER 3

METHODOLOGY
There are several unalterable factors in elevated serum homocysteine levels such
as heredity, age, and gender. However, there are other factors that are or maybe
alterable: these are diet and exercise. The purpose of the study was to determine if a 12week progressive exercise program, which met five days a week for 45 minutes would
significantly effect serum homocysteine levels in men and women.

Participants
Ten men and women between the ages of 32 and 50 years of age participated in
the study. The female subjects were all premenopausal. Subject’s homocysteine levels
were 10 umol/L or greater. The subjects were all sedentary, business or professional
individuals who joined the study to improve their physical fitness.

Subject Selection
Homocysteine has been widely researched and related to heart disease. The
University o f Nevada, Las Vegas exercise physiology laboratory conducts an
experimental exercise program, which studies the effect of daily exercise on the aging
process and on coronary risk factors. This program has been conducted for the past 26
years. The exercise program meets Monday through Friday for 45 minutes of exercise
each day. The program is a formally lead, progressive exercise program consisting of

26
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flexibility and stretching exercises, strength and muscular endurance exercises, and
cardio-respiratory exercises, (see Appendix A for exercise class details) In the fall of
2001 all 22 of the new exercise participants were recruited to participate in the present
study. In addition to the normal physical fitness test battery (see Appendix B for test
battery) and the usual blood profile, all new participants were also tested for
homocysteine levels. O f the 22 new participants 11 had homocysteine levels 10 umol/L
or greater and these 11 were identified to be in the study. One subject whose
homocysteine levels were extremely high was later eliminated as an outlier. The exercise
program is a year-long program. However, for the present study the new participants
were tested before and after 12 weeks. Previous results had shown that the major
changes in physical fitness occurred during the first 12 weeks. Those who participated in
the 12-week homocysteine study attended at least 75% of the exercise sessions. Table 1
presents the subjects physical characteristics.

Table 1 Physical Characteristics of Subjects
Subjects
Height (In) W eghtlO is) %Fat
MALES
1
70
177
26
2
74
225
36
3
70
177
26
4
69
170
23
5
70
180
26
6
73
185
29
Mean for males
71
186
28
FEMALES
7
53
125
28
8
52
120
32
9
51
118
29
10
53
175
38
Mean for females
52
32
135

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

28
Pre-exercise Physical Fitness Assessment
Prior to the exercise program starting, the participant’s physical fitness was
assessed using a standard physical fitness test battery. The physical fitness test battery
consisted of items to evaluate flexibility, strength and muscular endurance, cardio
respiratory fitness, and body composition, (see appendix B for complete test battery)
Participants were asked to not change their diets or physical activity levels and not to
begin any diet supplementation, so that the only factor affecting any possible change in
their homocystiene levels would be the daily exercise.

The Exercise Program
After the physical fitness assessment was completed, the 12- week exercise
program was started. Participants met Monday through Friday and participated in a
progressive general exercise class. Attendance was taken daily. The class started at an
intensity o f approximately 35-50% of V02 max and increased intensity weekly so that at
the end of the 12-week period, participants were working at an intensity of approximately
85% of maximum oxygen uptake. The exercises stressed warm-up and stretching,
muscular strength and endurance, cardio-respiratory exercises and a cool down period
(See Appendix A for exercise class details).

Post-Experimental Period
At the end of the 12 weeks of exercise all physical fitness tests were repeated and
homocystiene levels were again determined.
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Homocysteine Determination
Homocysteine levels were determined at a local medical laboratory. Subjects
were asked to report to the medical laboratory after a 14 hour fast during which no food
or drink, other than a reasonable quantity of water for thirst. Subjects were asked not to
exercise 12 hours before reporting to the laboratory and were asked to get at least 8 hours
of sleep the previous night. Three 10ml syringes of blood were drawn from the
antecubital vein. The blood was centrifuged and 10 cc were used to determine serum
homocysteine. Homocysteine ultraquant was determined by a micro particle enzyme
immunoassay procedure.

Statistical Analysis
The purpose of the study was to investigate the effects of a daily 12-week exercise
program on homocysteine levels.
Ho: Exercise has no effect on Homocysteine levels.
HI: Exercise reduces Homocysteine levels.
A dependent one tailed t test was performed to evaluate the changes in mean
homocysteine values, before and after the 12-week exercise program, (oc = .05)
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CHAPTER 4

RESULTS AND DISCUSSION
The purpose of the present study was to investigate the effects of a 12-week
exercise program on homocysteine levels in men and women. The research question was:
Does regular exercise reduce homocysteine levels? Homocysteine levels were
determined prior to the 12-week exercise program and again at the end of the 12-week
period. The homocysteine levels were then evaluated for any significant changes.

Subjects
Subjects in the study were business or professional men and women ranging from
32 to 50 years of age. All subjects were sedentary prior to the program and joined the
program to improve their physical fimess level. All subjects attended at least 75% of the
exercise sessions. Table 1 in chapter 3 presents the physical characteristics of the
subjects prior to the 12 week exercise program beginning. The females had a mean
weight of 128 lbs and a mean height of 64 inches. Their body composition was not
unusual for the average female, namely 29.8% body fat. The males were likewise normal
for the adult population with an average height and weight of 70.5 inches and 181 lbs.
The males’ percent body fat was 26.2%. The average attendance during the 12-weeks of
exercise was 79.2%. During the physical fitness testing following the 12 weeks of
exercise all tests items improved although weight and body composition did not
30
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change dramatically (see Appendix E for fitness test scores). Figure 2 and 3, and 4
present the changes in body composition, strength, and cardio-respiratory fitness levels.
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Figure 2. Changes in Body Composition in Men and Women.
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Cardio-Respiratory Changes in Men
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Figure 4.Cardio-Respiratory Changes in Men and Women

Data Analysis
A dependent t test was performed to evaluate the changes in homocysteine levels
following the exercise program (a = .05). The mean homocysteine level prior to the
exercise program was 12.47 umol/L and the mean homocysteine level after the 12-week
period was 11.18 umol/L. The mean difference was 1.29 from week 1 to week 12. Table
2 shows the individual values and the mean values of homocysteine.
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Table 2 Changes in Homocysteine

dlff.T1&T2
0.2
1.6
1.6
1.1
0.1
1.2
2.4
1.4
1.3
2
12.9
1.29
.714
0.23

HcyT2
10.1
11
11
10
12.6
13.7
12.7
9.1
10.3
11.3
111.8
11.18
1.43
0.45

H cvT l
10.3
12.6
12.6
11.1
12.7
14.9
15.1
10.5
11.6
13.3
124.7
12.47
1.66
0.53

Subject
1
2
3
4
5
6
7
8
9
10
Total
Mean
Standard Deviation
Standard Error

%attendance
80
82
78
81
76
75
83
84
77
76
792
79.2

Due to his extremely high levels of homocysteine subject 11 was considered an outlier
and was eliminated from the statistical analysis because he was not representative of the
population.
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Figure 5. Illustrates the changes in homocysteine over 12 weeks.
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The analysis revealed a significant difference in homocysteine levels after the 12-week
exercise program (t = 5.71, p<.05). The result of the statistical analysis provides
evidence that regular exercise does reduce homocysteine levels in men and women.

Table 3 Paired T test for changes in homocysteine
t-Test: Paired Two Sample for Means

Mean
Observations
Hypothesized Mean
Difference
df
t Stat
P(T<=t) one-tail
t Critical one-tail

Variable 1 Variable 2
12.47
11.18
10
10
0

9
5.712838
0.000145
1.833114

Discussion
The present study revealed a statistically significant change in homocysteine
levels after a 12-week exercise program. Six men and four women participated in the
study to improve their physical fitness. It was assumed that all women were
premenopausal based on the ages of the subjects ranged from 32 to 50 years of age. All
subjects reported that they were free of any known heart disease or any other major
medical condition. Subjects reported being sedentary prior to the exercise program and
were asked to refrain fi-om changing their diet or to begin taking any supplements other
than their multivitamin.
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The exercise program consisted of stretching, muscular strength and endurance,
cardio-respiratory exercise and a cool down. Attendance was taken and subjects attended
a minimum of 3 out of 5 days per week for the 12-week period.
A large volume of research has been published about homocysteine in the last
decade; however, to date little research has been published on the specific effects of
regular exercise and homocysteine levels. Nygard et al. (1995) showed a correlation
between exercise and homocysteine levels in the Norwegian Hordaland Homocysteine
study. However, Wright et al. (1998) showed that one bout of 30 minutes of acute
exercise has no effect on homocysteine levels.
It is an accepted fact in the medical population that elevated cholesterol levels are
a major risk factor for heart disease and that cholesterol can be lowered by regular
exercise and diet. Normal levels of cholesterol should be below 200 for total cholesterol
with LDL levels below 130 and HDL above 35. Exercise can increase HDL cholesterol
and lower total cholesterol. But there is only limited information about the effect of
regular exercise on serum homocysteine levels (Malinow et al., 1999; Spectra Cell Lab;
Franklin, 1998; Stein et al. 1998; Boushley et al., 1995). The present study gives
evidence that regular exercise lowered homocysteine levels.
Overall there was a 10% reduction in homocysteine levels over the 12 weeks and
while this is statistically significant there is a question whether, from a practical
preventive standpoint, this is a significant reduction. There is little research to indicate
the magnitude o f homocysteine reduction necessary to significantly reduce the risk of a
cardiovascular accident. It is possible that exercise for a longer period of time might
reduce homocysteine levels enough to show that homocysteine has been reduced enough
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to lessen the chance of cardiovascular disease. It would be especially important to
determine if homocysteine levels gradually decline with training and at what point
homocysteine has a plateau affect. However, even though the present study only showed
a slight decline in homocysteine levels with exercise, the trend was toward lowering
homocysteine levels. Perhaps, with the combination of exercise and diet, homocysteine
levels may be reduced to lessen the incidence of coronary heart disease.
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CHAPTER 5

SUMMARY, CONCLUSIONS AND RECOMMENDATIONS
Summary
Cardiovascular disease is the major cause of death in the United States. Elevated
serum homocysteine is an accepted risk factor for coronary heart disease along with
hypertension, uncontrolled diabetes, elevated cholesterol levels, cigarette smoking, lack
of exercise, and obesity. Homocysteine was originally discovered in the 1933 and
elevated levels were seen in children with mental retardation. However, research, which
showed the relationship between elevated homocysteine levels and coronary heart
disease, did not start imtil 1976 (Wilcken et al.,1976). Since then several studies have
related elevated homocysteine levels with heart disease (Boushley et al., 1995, Malinow
et al., 1994, Nygard et al., 1995, Stampfer et al., 1992, Kang et al., 1986, etc). Even
though most medical diagnostic laboratories indicate homocysteine levels between 5 and
15 umol/L to be a normal range, studies (Segala et al., 2000) have demonstrated that
homocystiene levels above 6.3 umol/L cause a progressive risk of a heart attack.
It has also been determined that elevated homocysteine is a heritable factor
(Malinow et al., 1996, Genest et al., 1991, Reed et al., 1991, Berg et al., 1992). Age,
gender, menopause, elevated cholesterol, diabetes, kidney disease, and Alzheimer’s
disease have also been linked to elevated homocysteine levels. However, little research
has been completed showing the relationship between regular exercise and homocysteine
37
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levels. Total cholesterol and particular low-density lipoproteins, which are both,
important in coronary heart disease, have been shown to be beneficially effected by
regular exercise. This relationship sparks an interest as to whether exercise may also
beneficially effect homocysteine levels.
The purpose of the current study was to determine whether a 12-week exercise
program lowered homocysteine levels in men and women. Homocysteine levels were
determined prior to the beginning of the 12-week period and again at the end of the 12
weeks. Homocysteine levels were then assessed for changes. A dependent t test revealed
a statistically significant decrease in homocysteine levels after the 12-week exercise
program.
In order to lower the risk for heart disease it is important to eat a healthy diet in
order to lower cholesterol levels and homocysteine levels and also supplement the diet
with Vitamin B12, B6, and folic acid if needed. The results of the present study indicate
that regular exercise also assists in lowering elevated homocysteine levels.

Conclusion
Twelve weeks o f regular, progressive exercise for 45 minutes five days a week,
produced a statistically significant reduction in serum homocysteine levels in 10 male and
female subjects.

Recommendations for Further Research
1. It is recommended that a larger number of subjects be studied. Ten subjects were
examined in the current study and more subjects may change the results of the
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study and would allow a better opportunity to make inferences about the general
population.
2. It is recommended that subject’s diets be more carefully assessed and controlled.
Subjects were asked not to change their diets during the experimental period and
it was assumed that all subjects were compliant with the request. However, a
daily diet record, and a record of supplement use would present evidence that it
was not dietary change that effected the homocysteine levels.
3. It is recommended that prior to subject selection that a questionnaire be completed
by all subjects to determine any use of medication, supplements, and vitamins,
and to indicate the amount and kind o f exercise they have participated in.
4. It is recommended that a longer exercise period be studied. Twelve weeks
produces changes in physical fitness but blood variables may need prolonged
activity to produce significant and meaningful changes.
5. It is recommended that different types of exercise programs be used. The present
study used an overall general fitness regimen. It would be desirable to determine
if changes occurred with a more intense aerobic training and/or with strictly
anaerobic training such as strength training.
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Exercise Class Description
The University of N evada, Las V egas Adult Exercise Research Program
is designed to im prove th e quality of lifestyle by providing a program
of physical ex ercise prescribed on th e basis of sound physiological and
biomedical principles.
The program of exercise starts at a low level of intensity and
p ro gresses in intensity each w eek . Time is needed to adapt to the
str ess of regular exercise.
The class m e e ts a s a group five d ays a w eek , Monday through Friday,
beginning in S ep tem b er and continuing through August. The program
has been m eeting for th e past 27 years and 25 individuals have been
in th e program for 20 years or m ore. With new people starting each
S ep tem b er there is now over a total of 100 people. New m em b ers that
start S ep tem b er are trained initially a s a sep arate group from th e
other ongoing m em bers. Both groups (beginning and old) m eet at th e
sa m e tim e, in th e sa m e facility, and share th e sa m e instructors, but
are exercised separately. In February, th e beginning group has
progressed sufficiently to join th e "on-going" class. The com bined
group then com p letes th e year a s on e class. The following S ep tem b er
th e cycle starts again.

The Testing Program.
The program includes laboratory evaluations of physical fitn ess, body
com position, blood pressure, heart rate, a com p lete blood profile, and
an electrocardiogram . A locker, exercise m at, surgical tubing, chinning
bar and th e daily exercise leadership are also provided. Medical
clearance from th e participant's personal physician is required prior to
starting th e program to determ ine w hether or not there is any
pathological reason why on e should not participate in this exercise
study. After receiving medical clearance and signing an informed
co n sen t form and a sp o u se a g reem en t form , participants will be tested
in the UNLV Exercise Physiology Laboratory, and a blood profile will be
taken at a local medical facility.
Although th e blood profile is an ex ecu tiv e panel, it has an
em p hasis on th e lipid item s: i.e. HDL C holesterol, LDL
41
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C holesterol, Total C holesterol, total/HDL ratio, triglycerides,
apolipoprotein A -1, B and their ratio (an excellen t biochem ical marker
of coronary heart d ise a se ). Additional blood com p on en ts such as
g lu co se, uric acid, electrolytes, blood e n zy m es and a com p lete CBC are
included. Physical fitn ess m easu rem en ts include cycle ergom eter te st,
m aximum oxygen uptake, body typ e (som atotyp e) photograph,
flexibility, stren gth, body com position (underw ater w eighing,
bioim pedance, and skinfolds) and th e heart's resp on se to exercise.
All th e se te s ts are adm inistered in S ep tem b er and in May during the
first year, and then each May thereafter. From our data, th e ch a n g es
that occur from S ep tem b er to May dramatically show th e beneficial
effect of regular exercise on coronary risk factors and physical
efficiency. The effect over tim e sh ow s that regular exercise preven ts
th e decline in fitn ess attributed to age.

The Exercise Program
The supervised exercise con sists of four com ponents: 1) w arm -up and
stretching, 2) strength and m uscular endurance, 3) cardiorespiratory
or aerobic, and 4 ) cool-dow n.
The warm-up period includes 5 -7 m inutes of flexibility ex ercises
consisting of bending, stretching and tw isting. T h ese ex ercise are
design ed to stretch th e m uscles while allowing th e joints to go through
their full range of m ovem en t. At th e beginning of th e year m ore tim e is
sp en t in this p h ase than later. Em phasis is put on e x ercises for low
back pain.
Exercises for muscular strength and endurance include calisthenics
such a s push-up, sit-u p s, c h est raising, chins etc. T h ese ex er cise s are
d esign ed to ex ercise each major m uscle group using th e body's w eight
a s resistan ce.
For th e aerobic or cardiorespiratory portion of the class; th e w om en
bench step and jo g , and th e m en bench step and sw im . Sw im m ing is
not a prerequisite of th e class sin ce th e university pool is divided into a
25-yard d eep pool and a 25-yard shallow pool. The beginning class
d o es w ater walking.
The final part of th e program is th e cool-down period during which
tim e th e body returns to its resting p re-exercise level. T h ese e x ercises
are similar to th e warm -up ex er cise s, and are m ore im portant in the
w om en's class a s th e h eat gen erated by th e exercise and jogging
n eed s to be dissipated, w h ereas th e sw im m ing ten d s to cool th e body
down in th e pool.
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The Research
The exercise research program stu d ies three main em p hasis: 1) th e
longitudinal effect of daily, regular exercise on th e factors that play a
role in th e d evelop m en t of heart d isea se. 2) the effect of short term
ex ercise on selected physiological variables; 3) th e effect of regular
ex ercise on th e aging process.
It is not a program for individuals who have a history of
heart d isea se , major risk factors or are sym ptom atic. It is
not a cardiac rehabilitation program. A ttendance is taken
each day and is an important com p onent of th e study.
70% atten d an ce (4 tim e a w eek ) is req uested although few busy
professional people can attain that atten d an ce. But regular atten d an ce
is encouraged since regular, progressive exercise is sa fe , w h ereas
sporadic, irregular exercise can be potentially dangerous. The
experim ental and progressive period is from Septem ber to May. During
th e su m m er th e program m e e ts four days a w eek and d o es not
progress in intensity.
In addition to th e ab ove research, class m em b ers are also able to
participate in other research stu d ies that th e laboratory conducts. This
is strictly voluntary. In th e past th e se stu d ies have included th e effect
of exercise on body com position, w eight loss, therm oregulation, diet
and blood pressure, certain blood variable, etc.

The Benefits
Research evid en ce (both ours and others) has show n that participation
in regular, vigorous ex ercise is extrem ely beneficial. In 1 9 9 6 the
Surgeon General of th e United S ta te s released th e Surgeon G eneral's
Report on Physical Activity and Health clearly sum m arizes th e se
benefits. Physiological and psychological ch an ges, which have been
shown with routine ex ercise, include:
• D ecrease in resting and ex ercise heart rate
• D ecrease in arterial blood pressure
■ In crease in cardiac efficiency
■ Im proved body com position (m ore m uscle and less fat)
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■ Reduction in total serum cholesterol and an increase in HDL
cholesterol
(th e good cholesterol)
■ Prevention of strength loss with age
■ Reducing, preventing or slowing down th e physiological effects of
aging
■ Im proved self-im age
■ Im proved s e n s e of w ell-being
• Reducing str e ss levels
C hanges such a s th e se , reduce th e risk of coronary heart d ise a se (the
leading ca u se of death in m en and w om en ); provide greater so u rces of
energy for work and leisure; and create a positive outlook toward life.

From Golding, Lawrence. (1992). Adult Exercise Research Program-Handbook.
Unpublished participants handbook. University of Nevada, Las Vegas.
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UNIVERSITY OF NEVADA, LAS VEGAS
A dult E x e rc is e P ro g ra m s-S c o re S h e e t
B e s u r e to fill in a ll s p a c e s
Subject’s Name:_____________

I D. Number:

Name of T ester:_____________

/
month
. Attendance (%):__
Date:

Age (yrs. day of test): _ Birthdate:_
1. Resting Heart Rate (bpm):.

I

day

year

2. Resting B.P. (mmhg):___l_

3. Weight (lbs):_ 4. Height (ins):_

5. EKG:

YES/NO

6. Skinfolds (mm)

(Done by:___) Caliper used circle: Lange I Harpenden
, Check off .
Chest: ______ mm
Triceps:_____ mm
1.
2.
Abdomen:
mm
Back: mm
3.
4.
Hip:
mm
Thigh: mm
5.
6.
Side:
mm Waist Girth:
cm 7.
8.
7. Step Test (post-exercise 1 min. HR):
beats 9.
8. Flexibility 2 triais-(ins.-circie best):

ins

9. Grip Strength (circle R or L):

R

10. Bench (reps):
11. Bike Test:

10.
11.

ins
L

kg

12.
13.
14.

Curls (reps): Crunches (1 min):
Seat height:

1 st W k.L d;____________ kgm

HR: 2'"’Min._____ 3"'min._____4“’ min_

12nd Wk.Ld:

j 3rd Wk Ld:

kam

H R :2 '“ Min._

_3"*min._

J 4th Wk.Ld:

kam

HR: 2""Min.

3"*min.

NOTE: Check boxes for workloads & heart rate to be used.

12. Photo (circle): Yes / No
(no shoes or socks)

13. Blood Appointment: Yes / No
(Give blood order form if not received!
14.C H EC K N O W - A R E ALL SPACES FILLED IN ?
P rin te d o u t: YES NO
PUT IN COMPUTER?
YES/NO
COMPLETE?
YES/NO
M ailed:
YES/NO

From Golding, Lawrence. (1992). Adult Exercise Research Program-Handbook.
Unpublished Participants handbook. University of Nevada, Las Vegas.
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Informed Consent
I, Tracey ZuehlsdorfF am a graduate student in the Exercise Physiology
department at the University of Nevada, Las Vegas. As a graduate student I am working
on my thesis and conducting a research project to determine the effects of a 12-week
training program on homocysteine levels in men and women. I invite you to participate
and act as a subject in this research project. The study is 12 weeks in length and prior to
the training program, hlood tests will be done to determine homocysteine levels. Those
with homocysteine levels above 10 umol/L will undergo a 12-week aerobic type exercise
program at least three times a week. At the end of the 12 weeks, homocysteine levels
will be evaluated again.
There are many benefits to participating. First, your involvement will help
discover the effects that exercise have on homocystiene levels, a new risk factor for heart
disease. As well, there are many personal benefits to exercise such as weight loss,
reducing cholesterol, controlling hypertension, and fighting other risk factors for heart
disease. There is no cost to you as a subject and all information concerning you is
confidential and will be in file locked in a cabinet in Dr. Larry Golding’s office.
If you have any questions concerning the project please contact myself, Tracey
Zuehlsdorff at 437 - 8745 or Dr. Larry Golding (SIRC 100) at 895 - 3766. For any
questions about the rights of research subjects, contact the Office for the Protection of
Research Subjects at 895 - 2794.
Participation in this study is voluntary and one may withdraw at any time during
the study; however, your full participation is greatly appreciated.

I wish to participate

Date
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Raw Data

Subject
1
2
3
4
5
6
7
8
9
10

Mean
SD
Std error

hoy wk 1 hoy wk 12 difference
10.3
12.6
12.6
11.1
12.7
14.9
15.1
10.5
11.6
13.3
12.47
1.660689
0.525156

10.1
11
11
10
12.6
13.7
12.7
9.1
10.3
11.3
11.18
1.430462
0.452352

0.2
1.6
1.6
1.1
0.1
1.2
2.4
1.4
1.3
2
1.29
0.714065
0.225807

t-Test: Paired Two Sample for Means
Variable 1 Variable 2
Mean
12.47
11.18
Observations
10
10
Hypothesized Mean Dr
0
df
9
t Stat
5.712838
P(T<=t) one-tail
0.000145
1.833114
t Critical one-tail
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Changes in Body Composition

% Fat
Subject Wt (lbs)
W ki Wk12 W ki Wk12
Males
175
26
25
1
177
210
36
30
2
225
175
177
26
26
3
170
23
22
4
170
180
175
26
25
5
185
29
180
25
6
Mean
186
181
28
25
Females
7
125
120
28
23
8
120
120
32
26
9
118
120
29
25
10
175
170
38
31
Mean
134
132
32
26
29
26
Total avg 165
161

Ht(in)
W ki Wk12
70
74
70
69
70
73

70
74
70
69
70
73

71

71

53
52
51
53

53
52
51
53

52
63

52
63

Changes in Strength
Subject Bench*
Curls*
SitUps*
Grip*
W ki Wk12 W ki Wk12 W ki Wk12 W ki Wk12
Males
42
1
12
16
13
15
30
38
30
2
15
10
9
16
25
33
28
40
11
12
3
10
15
33
40
36
42
41
4
14
16
10
16
36
15
30
5
9
15
11
30
38
15
36
29
11
6
9
16
11
25
32
28
40
Mean
11
15
11
14
30
32
40
30
Females
7
10
15
10
13
30
38
32
41
17
8
12
9
15
32
41
32
45
14
9
13
32
10
15
28
30
40
10
3
6
6
10
16
26
25
36
26
34
Mean
9
13
9
13
30 40.0
Total avg
10
14
10
14
28
33
30
40
‘ Note; Bench, Curls, and Sit Ups are m easured in repetitions and Grip
Strength is m easured in Kg.
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Cardiovascular Fitness Changes

Subjects RHR
W ki
Maies
1
81
2
83
3
88
4
77
5
76
6
81
Mean
81
Females
7
84
83
8
9
81
10
86
Mean
83
82
Total avg

V02(ml/kg) Step Test
PWC(kg
BP-S/D
Wk12
Wk12 W ki Wk12 W ki Wk12 W ki Wk12 W ki
72
71
73
69
68
72

130/90
120/95
135/85
130/80
145/90
155/95

125/85
120/85
130/80
130/80
130/90
145/85

1000
900
1100
900
850
950

1400
1200
1250
1150
1200
1350

33
26
34
30
26
30

36
32
35
33
32
36

129
136
123
116
125
132

109
110
112
108
110
116

71

136/89 132/84

950

1258

30

34

127

111

70
71
72
81

130/85
135/90
140/80
145/90

125/80
130/85
130/75
140/80

980
800
950
800

1250
1100
1250
1100

29
26
25
21

32
31
28
30

136
140
136
152

110
121
119
135

73
71

137/86 131/80
136/88 130/82

882
928

1175
1228

25
28

30
32

141
132

121
115
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